Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Stenner

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Annals of Surgical Oncology|January 6, 2011
Selective intra-arterial chemotherapy with floxuridine as second- or third-line approach in patients with unresectable colorectal liver metastasesPanagiotis Samaras, S Breitenstein, S R Haile, et al.
The American Journal of Pathology|April 6, 2001
Expression and potential role of Fas-associated phosphatase-1 in ovarian cancerI Meinhold-Heerlein, F Stenner-Liewen, H Liewen, et al.
Hematological Oncology|December 10, 2020
Clinical characteristics and outcome of patients over 60 years with Hodgkin lymphoma treated in SwitzerlandA A Moccia, S Aeppli, S Güsewell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2025
Adjuvant nivolumab versus placebo for high-risk muscle-invasive urothelial carcinoma: 5-year efficacy and ctDNA results from CheckMate 274M D Galsky, J E Gschwend, M I Milowsky, et al.
Immuno-Oncology Technology|January 13, 2025
Adoptive cell therapy with tumor-infiltrating lymphocytes in combination with nivolumab in patients with advanced melanomaD König, B Kasenda, M Sandholzer, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Annals of Surgical Oncology|January 6, 2011
Selective intra-arterial chemotherapy with floxuridine as second- or third-line approach in patients with unresectable colorectal liver metastasesPanagiotis Samaras, S Breitenstein, S R Haile, et al.
The American Journal of Pathology|April 6, 2001
Expression and potential role of Fas-associated phosphatase-1 in ovarian cancerI Meinhold-Heerlein, F Stenner-Liewen, H Liewen, et al.
Hematological Oncology|December 10, 2020
Clinical characteristics and outcome of patients over 60 years with Hodgkin lymphoma treated in SwitzerlandA A Moccia, S Aeppli, S Güsewell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2025
Adjuvant nivolumab versus placebo for high-risk muscle-invasive urothelial carcinoma: 5-year efficacy and ctDNA results from CheckMate 274M D Galsky, J E Gschwend, M I Milowsky, et al.
Immuno-Oncology Technology|January 13, 2025
Adoptive cell therapy with tumor-infiltrating lymphocytes in combination with nivolumab in patients with advanced melanomaD König, B Kasenda, M Sandholzer, et al.
Pageof 2